Allero Therapeutics Receives EIC Horizon Grant to Advance Treatment of Celiac Disease

Allero Therapeutics BV, a Dutch oromucosal immunotherapy company, today announced that the Company has received a EUR 2.5 million EIC Horizon Grant provided by the European Commission to advance novel […]

Weiterlesen